REG - Bridgepoint Group - Issue of Equity

BridgepointAnnouncement

09/02/2026 11:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260209:nRSI2630Sa&default-theme=true

RNS Number : 2630S  Bridgepoint Group plc  09 February 2026

 

Bridgepoint Group plc
("Bridgepoint" or the "Company")

 

Issue of Equity

The transaction through which the Company added Energy Capital Partners
Holdings, LP and affiliated entities to the platform (the "Transaction") was
implemented by way of an Up-C Structure, involving the issue of 185 million OP
Units on Closing which are exchangeable for new shares in the capital of the
Company on a one-for-one basis. The Transaction was approved by Shareholders
on 19 October 2023.

The Company has received exchange notices in respect of 30 million of the OP
Units held by the ECP Sellers and therefore it announces that it intends to
issue 30 million ordinary shares of £0.00005 each ("New Ordinary Shares").
The New Ordinary Shares will rank pari passu with existing ordinary shares in
issue.

An application has been made for the admission of the New Ordinary Shares to
trading on the LSE's main market for listed securities.

Admission is expected to occur on 12 February 2026.

Capitalised terms not otherwise defined in this announcement have the meanings
given to them in the circular in respect of the Transaction dated 2 October
2023.

 

ENQUIRIES:

 

Bridgepoint

 

 Analysts and investors          Media

 Adam Key                        Christian Jones

 adam.key@bridgepointgroup.com   christian.jones@bridgepointgroup.com

 +44 7833 748010                 +44 20 7034 3500

 

FGS Global (Public Relations Adviser to Bridgepoint)

 

James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

bridgepoint-LON@fgsglobal.com

 

Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEAKCBKDBKDOBK



            Copyright 2019 Regulatory News Service, all rights reserved